BioRestorative Therapies
BRTX
15 hedge funds and large institutions have $406K invested in BioRestorative Therapies in 2024 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 3 increasing their positions, 2 reducing their positions, and 2 closing their positions.
50% more first-time investments, than exits
New positions opened: 3 | Existing positions closed: 2
50% more repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 2
7% more funds holding
Funds holding: 14 → 15 (+1)
7% more capital invested
Capital invested by funds: $381K → $406K (+$25K)
0.92% more ownership
Funds ownership: 3.17% → 4.1% (+0.92%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SG
StoneX Group
New York
|
+$77.6K |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$33.2K |
| 3 |
UBS Group
Zurich,
Switzerland
|
+$24.1K |
| 4 |
Morgan Stanley
New York
|
+$15.5K |
| 5 |
NDSI
Newman Dignan & Sheerar Inc
Providence,
Rhode Island
|
+$1.55K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
-$34.8K |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$22.2K |
| 3 |
Geode Capital Management
Boston,
Massachusetts
|
-$1.52K |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
-$888 |
BRTX Hedge Fund Activity: Q4 2024 in Review
15 of the 7,602 institutional investors tracked by Wall St. Rank reported a position in BioRestorative Therapies (BRTX) for Q4 2024, worth a combined $406K — up 6.6% from $381K a quarter earlier.
Buyers outnumbered sellers: 3 funds opened new BRTX positions and 2 closed out — a net gain of 1 holder — while 3 added to existing stakes and 2 trimmed.
The largest buyer was StoneX Group, opening a new position worth an estimated $77.6K. The largest seller was Renaissance Technologies, exiting entirely with an estimated $34.8K sold.
- 15 institutional investors held BioRestorative Therapies (BRTX) as of Q4 2024, up from 14 in Q3 2024.
- Funds reported $406K of BioRestorative Therapies stock for Q4 2024, up 6.6% quarter-over-quarter.
- 3 funds opened new BioRestorative Therapies positions in Q4 2024 and 2 closed out, a net change of +1 holder.
- The largest BioRestorative Therapies buyer in Q4 2024 was StoneX Group, an estimated $77.6K added.
- The largest BioRestorative Therapies seller in Q4 2024 was Renaissance Technologies, an estimated $34.8K sold.
Based on aggregated 13F filings for Q4 2024.